ARD-2128
ARD-2128 is a potent, orally active PROTAC degrader of the androgen receptor (AR) . It effectively reduces AR protein levels, inhibits AR-driven gene expression, and suppresses tumor growth in prostate cancer models, demonstrating utility for both in vitro and in vivo research applications.
Product Specifications
CAS Number
2222111-87-5
Product Name Alternative
Inhibit, orally, Inhibitor, cancer, bioavailable, ARD2128, ARD-2128, ARD 2128, AR-regulated, Androgen Receptor, AndrogenReceptor, prostate, PROTACs, tumor
Field of Research
Metabolism Research, Pharmacology & Drug Discovery
Purity
98.80% (May vary between batches)
Solubility
DMSO:100 mg/mL (121.9 mM)
Smiles
O=C1C=2C (C (=O) N1C3C (=O) NC (=O) CC3) =CC=C (C2) N4CCC (CN5CCN (CC5) C6=CC=C (C (N[C@@H]7C (C) (C) [C@@H] (OC8=CC (Cl) =C (C#N) C=C8) C7 (C) C) =O) C=C6) CC4
Molecular Formula
C45H50ClN7O6
Molecular Weight
820.37
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
GTR15151559 1 Vial
Lentiviral mouse Hmgb3 shRNA (UAS) - Lentiviral mouse Hmgb3 shRNA (UAS, RFP) (25)
Sign In for Pricing
View Details